| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |